{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T15:19:32Z","timestamp":1777648772585,"version":"3.51.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,1,1]],"date-time":"2000-01-01T00:00:00Z","timestamp":946684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2000,12,28]],"date-time":"2000-12-28T00:00:00Z","timestamp":977961600000},"content-version":"vor","delay-in-days":362,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2000,1]]},"DOI":"10.1016\/s0735-1097(99)00525-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T11:21:35Z","timestamp":1027596095000},"page":"1-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":413,"title":["The evolving role of statins in the management of atherosclerosis"],"prefix":"10.1016","volume":"35","author":[{"given":"Carl J","family":"Vaughan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Antonio M","family":"Gotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig T","family":"Basson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0735-1097(99)00525-2_BIB1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth","volume":"21","author":"Brown","year":"1980","journal-title":"J Lipid Res"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB2","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1161\/01.CIR.80.5.1313","article-title":"HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels","volume":"80","author":"Kostner","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB3","first-page":"2732","article-title":"Altered disposition of pravastatin following concomitant drug therapy with cyclosporine A in transplant recipients","volume":"25","author":"Regazzi","year":"1993","journal-title":"Transplant Proc"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.1984.03340270029025","article-title":"The Lipid Research Clinics Coronary Primary Prevention Trial results","volume":"251","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM198711123172001","article-title":"Helsinki Heart Study","volume":"317","author":"Frick","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB7","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199011083231901","article-title":"Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B","volume":"323","author":"Brown","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB8","doi-asserted-by":"crossref","first-page":"969","DOI":"10.7326\/0003-4819-119-10-199311150-00002","article-title":"Coronary angiographic changes with lovastatin therapy","volume":"119","author":"Blankenhorn","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB9","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/01.CIR.89.3.959","article-title":"Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography","volume":"89","author":"Waters","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB10","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB11","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1161\/01.CIR.91.10.2528","article-title":"Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels","volume":"91","author":"Jukema","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB12","doi-asserted-by":"crossref","unstructured":"Pitt B, Mancini JGB, Ellis SG, et al, for the PLAC-I Investigators. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I): reduction in atherosclerosis progression and clinical events. J Am Coll Cardiol 1995;26:1133\u20139.","DOI":"10.1016\/0735-1097(95)00301-0"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/oxfordjournals.eurheartj.a015224","article-title":"The effect of simvastatin on progression of coronary artery disease","volume":"18","author":"Bestehorn","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S0002-9149(97)00346-9","article-title":"Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS])","volume":"80","author":"Herd","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB16","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1161\/01.CIR.87.6.1781","article-title":"Lipid-lowering and plaque regression","volume":"87","author":"Brown","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(96)05190-2","article-title":"Statins do more than just lower cholesterol","volume":"348","author":"Vaughan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB18","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB19","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB20","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB21","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0735-1097(98)00202-2","article-title":"Effect of pravastatin on cardiovascular events in women after myocardial infarction","volume":"32","author":"Lewis","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB22","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB23","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB24","first-page":"1329","article-title":"Second report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)","volume":"89","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.97.15.1453","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"97","author":"Pedersen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB26","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/01.CIR.97.15.1446","article-title":"Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the cholesterol and recurrent events trial","volume":"97","author":"Sacks","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1161\/01.CIR.97.15.1440","article-title":"Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS)","volume":"97","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0140-6736(95)92836-7","article-title":"Cholesterol, diastolic blood pressure, and stroke","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJM198904063201405","article-title":"Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial","volume":"320","author":"Iso","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB30","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/01.STR.28.11.2315","article-title":"Vascular effects of statins in stroke","volume":"28","author":"Delanty","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB31","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/01.STR.28.5.946","article-title":"Stroke, statins, and cholesterol","volume":"28","author":"Blauw","year":"1997","journal-title":"Stroke"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB32","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0002-9149(99)80580-3","article-title":"Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)","volume":"75","author":"Crouse","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB34","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1161\/01.CIR.97.18.1784","article-title":"Effects of lowering average or below-average cholesterol levels on the progression of carotid atherosclerosis","volume":"97","author":"MacMahon","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB35","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archinte.1997.00440330039004","article-title":"Reductase inhibitor monotherapy and stroke prevention","volume":"157","author":"Crouse","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB36","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1161\/01.CIR.89.6.2519","article-title":"Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia","volume":"89","author":"Egashira","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB37","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM199502233320801","article-title":"Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease","volume":"332","author":"Treasure","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM199502233320802","article-title":"The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion","volume":"332","author":"Anderson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB39","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month","volume":"95","author":"O\u2019Driscoll","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB40","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB41","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1161\/01.CIR.89.4.1530","article-title":"Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease","volume":"89","author":"Gould","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB42","doi-asserted-by":"crossref","unstructured":"Eichstadt HW, Eskotter H, Hoffman I, et al. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. Am J Cardiol 1995;76:122\u20135A.","DOI":"10.1016\/S0002-9149(06)80027-5"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB43","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJM199812313392703","article-title":"Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam-computed tomography","volume":"339","author":"Callister","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB44","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/01.CIR.95.2.324","article-title":"Effects of cholesterol reduction on myocardial ischemia in patients with coronary artery disease","volume":"95","author":"Andrews","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB45","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1161\/01.CIR.94.7.1503","article-title":"Reduction of transient myocardial ischemia with pravastatin in addition to conventional treatment in patients with angina pectoris","volume":"94","author":"van Boven","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.ATV.16.7.831","article-title":"The yin and yang of oxidation in the development of the fatty streak","volume":"16","author":"Navab","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB47","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1172\/JCI116590","article-title":"Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate","volume":"92","author":"Parhami","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB48","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1073\/pnas.85.8.2805","article-title":"Lysophosphatidylcholine","volume":"85","author":"Quinn","year":"1988","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.RES.80.6.810","article-title":"Induction of P-selectin by oxidized lipoproteins","volume":"80","author":"Vora","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB50","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1172\/JCI116670","article-title":"Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques","volume":"92","author":"O\u2019Brien","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0026-0495(92)90263-A","article-title":"Lovastatin inhibits LDL oxidation and alters its fluidity and uptake by macrophages","volume":"41","author":"Aviram","year":"1992","journal-title":"Metabolism"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB52","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0735-1097(97)00158-7","article-title":"Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine","volume":"30","author":"Chen","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB53","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1161\/01.ATV.17.8.1521","article-title":"Effects of fluvastatin on leukocyte-endothelial cell adhesion in hypercholesterolemic rats","volume":"17","author":"Kimura","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1161\/01.ATV.13.7.1013","article-title":"Oxidized LDL-induced leukocyte\/endothelium interaction in vivo involves the receptor for platelet activating factor","volume":"13","author":"Lehr","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB55","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0735-1097(97)00324-0","article-title":"HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia","volume":"30","author":"Weber","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB56","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/hrt.69.5.377","article-title":"Risk of thrombosis in human atherosclerotic plaques","volume":"69","author":"Davies","year":"1993","journal-title":"Br Heart J"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB57","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB58","doi-asserted-by":"crossref","first-page":"8154","DOI":"10.1073\/pnas.88.18.8154","article-title":"Location of stromelysin gene in atherosclerotic plaques using in situ hybridisation","volume":"88","author":"Henney","year":"1991","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(89)90953-7","article-title":"Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques","volume":"2","author":"Richardson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.95.3.594","article-title":"Tissue factor modulates the thrombogenicity of human atherosclerotic plaque","volume":"95","author":"Toschi","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB61","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1161\/01.ATV.17.2.265","article-title":"Vastatins inhibit tissue factor in cultured human macrophages","volume":"17","author":"Colli","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB62","doi-asserted-by":"crossref","unstructured":"Rogler G, Lackner KJ, Schmitz G. Effects of fluvastatin on growth of porcine and human vascular smooth muscle cells in vitro. Am J Cardiol 1995;76:114\u20136A.","DOI":"10.1016\/S0002-9149(06)80025-1"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB63","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0005-2760(96)00184-1","article-title":"Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors","volume":"1345","author":"Negre-Aminou","year":"1997","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB64","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00005344-199805000-00017","article-title":"Direct effects of statins on the vascular wall","volume":"31","author":"Corsini","year":"1998","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB65","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1074\/jbc.270.1.319","article-title":"Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase","volume":"270","author":"Liao","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB67","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1172\/JCI117221","article-title":"Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells","volume":"93","author":"Rosenkranz-Weiss","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB68","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1161\/01.CIR.95.2.311","article-title":"Arginine","volume":"95","author":"Cooke","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1126\/science.2116664","article-title":"The cellular functions of small GTP-binding proteins","volume":"249","author":"Hall","year":"1990","journal-title":"Science"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB70","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1172\/JCI115599","article-title":"Isoprenoid metabolism is required for stimulation of the respiratory burst oxidase of HL-60 cells","volume":"89","author":"Bokoch","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB71","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJM199201303260506","article-title":"The pathogenesis of coronary artery disease and acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB72","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/01.ATV.11.2.395","article-title":"Platelet deposition at high shear rates is enhanced by high plasma cholesterol levels","volume":"11","author":"Badimon","year":"1991","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB74","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1161\/01.ATV.15.2.247","article-title":"Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia","volume":"15","author":"Notarbartolo","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB75","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0009-9236(97)90104-1","article-title":"Platelet alpha2-adrenergic receptors in hypercholesterolemia","volume":"61","author":"Baldassarre","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0021-9150(92)90245-C","article-title":"Biochemical and functional alterations associated with hypercholesterolemia in platelets from hypertensive patients","volume":"94","author":"Mazeaud","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB77","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.ATV.15.6.759","article-title":"Platelet cytosolic Ca2+and membrane dynamics in patients with hypercholesterolemia","volume":"15","author":"Le Quan Sang","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB78","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/BF01696223","article-title":"Effects of long-term treatment with lovastatin on the clotting system and blood platelets","volume":"64","author":"Mayer","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB79","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1161\/01.CIR.92.11.3172","article-title":"Hyperlipidaemia and coronary disease","volume":"92","author":"Lacoste","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB80","first-page":"59","article-title":"Influence of cholesterol lowering on plasma membrane lipids and cationic transport systems","volume":"12","author":"Linjen","year":"1994","journal-title":"J Hypertens"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB81","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1161\/01.CIR.95.6.1370","article-title":"Low-density lipoproteins inhibit the Na+\/H+ antiport in human platelets","volume":"95","author":"Nofer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB82","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ajh.2830440208","article-title":"Elevated plasma levels of vascular endothelial cell markers in patients with hypercholesterolemia","volume":"44","author":"Wada","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB83","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0021-9150(86)90099-7","article-title":"The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis","volume":"62","author":"Armstrong","year":"1989","journal-title":"Atherosclerosis"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB84","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.ATV.19.5.1162","article-title":"Proteoglycans\u2019 contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix","volume":"19","author":"Lundstam","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB85","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/jama.1995.03530220037029","article-title":"Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein (a)","volume":"274","author":"Maher","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB86","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0735-1097(97)00129-0","article-title":"Platelet-dependent thrombin generation in patients with hyperlipidemia","volume":"30","author":"Aoki","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB87","doi-asserted-by":"crossref","first-page":"52B","DOI":"10.1016\/S0002-9149(98)00039-3","article-title":"Use of niacin, statins, and resins in patients with combined hyperlipidemia","volume":"81","author":"Brown","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/S0735-1097(99)00525-2_BIB88","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-125-7-199610010-00001","article-title":"Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and \u201cnormal\u201d cholesterol levels","volume":"125","author":"Pasternak","year":"1996","journal-title":"Ann Intern Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109799005252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109799005252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T12:25:39Z","timestamp":1760012739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109799005252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,1]]}},"alternative-id":["S0735109799005252"],"URL":"https:\/\/doi.org\/10.1016\/s0735-1097(99)00525-2","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2000,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolving role of statins in the management of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0735-1097(99)00525-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 American College of Cardiology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}